Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.

Dufva O, Kankainen M, Kelkka T, Sekiguchi N, Awad SA, Eldfors S, Yadav B, Kuusanmäki H, Malani D, Andersson EI, Pietarinen P, Saikko L, Kovanen PE, Ojala T, Lee DA, Loughran TP Jr, Nakazawa H, Suzumiya J, Suzuki R, Ko YH, Kim WS, Chuang SS, Aittokallio T, Chan WC, Ohshima K, Ishida F, Mustjoki S

Open source

DOI: 10.1038/s41467-018-03987-2
Published: 2018 Apr 19
Container: Nature communications
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41467-018-03987-2,
  title = {Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.},
  author = {Dufva O and Kankainen M and Kelkka T and Sekiguchi N and Awad SA and Eldfors S and Yadav B and Kuusanmäki H and Malani D and Andersson EI and Pietarinen P and Saikko L and Kovanen PE and Ojala T and Lee DA and Loughran TP Jr and Nakazawa H and Suzumiya J and Suzuki R and Ko YH and Kim WS and Chuang SS and Aittokallio T and Chan WC and Ohshima K and Ishida F and Mustjoki S},
  year = {2018},
  journal = {Nature communications},
  doi = {10.1038/s41467-018-03987-2},
  url = {https://doi.org/10.1038/s41467-018-03987-2}
}

RIS

TY  - JOUR
TI  - Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
AU  - Dufva O
AU  - Kankainen M
AU  - Kelkka T
AU  - Sekiguchi N
AU  - Awad SA
AU  - Eldfors S
AU  - Yadav B
AU  - Kuusanmäki H
AU  - Malani D
AU  - Andersson EI
AU  - Pietarinen P
AU  - Saikko L
AU  - Kovanen PE
AU  - Ojala T
AU  - Lee DA
AU  - Loughran TP Jr
AU  - Nakazawa H
AU  - Suzumiya J
AU  - Suzuki R
AU  - Ko YH
AU  - Kim WS
AU  - Chuang SS
AU  - Aittokallio T
AU  - Chan WC
AU  - Ohshima K
AU  - Ishida F
AU  - Mustjoki S
PY  - 2018
JO  - Nature communications
DO  - 10.1038/s41467-018-03987-2
UR  - https://doi.org/10.1038/s41467-018-03987-2
ER  -

APA

O, D., M, K., T, K., N, S., SA, A., S, E., B, Y., H, K., D, M., EI, A., P, P., L, S., PE, K., T, O., DA, L., Jr, L. T., H, N., J, S., R, S., YH, K., WS, K., SS, C., T, A., WC, C., K, O., F, I., & S, M. (2018). Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.. Nature communications. https://doi.org/10.1038/s41467-018-03987-2

Source records

pubmed · retrieved 2026-09-26T14:13:34.438Z
europe-pmc · retrieved 2026-09-26T14:13:34.440Z
doaj · retrieved 2026-09-26T14:13:34.411Z